These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2835557)

  • 1. Alloantibodies, autoantibodies, and immune complexes in patients with lung cancer.
    Górny MK; Lawniczak M; Jenek R; Słowik-Gabryelska A; Kaczmarek E; Zeromski J
    Lung; 1988; 166(2):97-105. PubMed ID: 2835557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-elastin antibodies in patients with lung cancer.
    Gmiński J; Mykała-Cieśla J; Machalski M; Drózdz M
    Immunol Lett; 1992 Jul; 33(2):211-5. PubMed ID: 1332926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of alloantibodies and immune complexes in bronchial secretions of lung cancer patients.
    Górny MK; Lawniczak M; Skrzypczak A; Zeromski J
    Neoplasma; 1987; 34(2):189-98. PubMed ID: 3600884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological significance of circulating IgG anti-IgE complexes.
    Paganelli R; Quinti I
    Monogr Allergy; 1989; 26():184-97. PubMed ID: 2788813
    [No Abstract]   [Full Text] [Related]  

  • 5. Measurement and evaluation of serum anti-p53 antibody levels in patients with lung cancer at its initial presentation: a prospective study.
    Segawa Y; Kageyama M; Suzuki S; Jinno K; Takigawa N; Fujimoto N; Hotta K; Eguchi K
    Br J Cancer; 1998 Sep; 78(5):667-72. PubMed ID: 9744508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.
    Winter SF; Minna JD; Johnson BE; Takahashi T; Gazdar AF; Carbone DP
    Cancer Res; 1992 Aug; 52(15):4168-74. PubMed ID: 1322237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental induction of immunity by anti-idiotypic vaccines against small-cell-lung cancer].
    Li Y; Hu JY; Zhang Y; Zhu MJ; Zhao XT
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):269-72. PubMed ID: 15996316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies.
    Dropcho EJ; King PH
    Ann Neurol; 1994 Aug; 36(2):200-5. PubMed ID: 8053656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A highly sensitive particle agglutination assay for the detection of P53 autoantibodies in patients with lung cancer.
    Agaylan A; Binder D; Sauer M; Neuweiler H; Meyer O; Kiesewetter H; Salama A
    Cancer; 2007 Dec; 110(11):2502-6. PubMed ID: 17932907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection and characterization of antigen component of circulating immune complex in sera from patients with lung cancer by monoclonal and polyclonal antibodies].
    Xue W; Hou J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Apr; 13(2):96-100. PubMed ID: 1652382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer.
    Brichory FM; Misek DE; Yim AM; Krause MC; Giordano TJ; Beer DG; Hanash SM
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9824-9. PubMed ID: 11504947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-idiotypic antibodies to anti-PDC-E2 in primary biliary cirrhosis and normal subjects.
    Chen QY; Rowley MJ; Mackay IR
    Hepatology; 1999 Mar; 29(3):624-31. PubMed ID: 10051459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?
    Liu L; Liu N; Liu B; Yang Y; Zhang Q; Zhang W; Yu P; Jin Y; Guo J; Guan S; Sun S; Miao L; Wei J
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1737-42. PubMed ID: 22699933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine tuning of epitopic dominance induced by lung cancer on the IgG response to bovine betalactoglobulin: towards a paraneoplastic immune marker.
    Michils A; Lambert JP; Yernault JC; Fabry V; Gossart B; Duchateau J
    Cancer; 1996 Feb; 77(4):657-64. PubMed ID: 8616757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes and autoantibodies in lung cancer.
    Guy K; Di Mario U; Irvine WJ; Hunter AM; Hadley A; Horne NW
    Br J Cancer; 1981 Mar; 43(3):276-83. PubMed ID: 7225280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgE/anti-IgE immune complexes in sera from patients with Crohn's disease do not contain food-specific IgE.
    Huber A; Genser D; Spitzauer S; Scheiner O; Jensen-Jarolim E
    Int Arch Allergy Immunol; 1998 Jan; 115(1):67-72. PubMed ID: 9430498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancer.
    Rossen RD; Reisberg MA; Hersh EM; Gutterman JU
    J Natl Cancer Inst; 1977 May; 58(5):1205-15. PubMed ID: 323505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of different methods for detecting circulating immune complexes. Studies in patients with lung cancer.
    Füst G; Fekete B; Angyal I; Jakab A; Pál A; Merétey K; Falus A; Török K; Szegedi G; Kávai M; Puskás E; Csécsi-Nagy M; Szabó T; Lenkey A; Misz M
    J Immunol Methods; 1981; 46(3):259-76. PubMed ID: 6975788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of autoantibodies to livin and survivin in Sera from lung cancer patients.
    Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Shijubo Y; Abe S; Hirohashi Y; Torigoe T; Sato N; Watanabe N
    Lung Cancer; 2005 May; 48(2):217-21. PubMed ID: 15829321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.
    Antes U; Heinz HP; Loos M
    Arthritis Rheum; 1988 Apr; 31(4):457-64. PubMed ID: 3258749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.